FDA Inspection 1169025 — HCSC Blood Center
The FDA completed an inspection of HCSC Blood Center on Apr 27, 2022 in Reading, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Reading, PA (United States)